| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 0ZM2Z182GD |
| InChI Key | CWHUFRVAEUJCEF-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C18H21F3N6O2 |
| Molecular Weight | 410.4 |
| AlogP | 1.81 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 89.63 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 29.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | PI3-kinase class I inhibitor | PubMed |
| Primary Target | |
|---|---|
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
Atypical protein kinase FRAP subfamily
|
- | 94-4600 | 19 | 199 | - | |
|
Enzyme
Kinase
Protein Kinase
Atypical protein kinase group
Atypical protein kinase PIKK family
|
- | 94-4600 | 1800 | 199 | - | |
|
Enzyme
Transferase
|
- | 20-216 | 130 | 20 | 82 | |
|
Enzyme
|
- | 20-216 | 130 | 14000 | 82 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | D015451 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Thymoma | 2 | D013945 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 2 | D020522 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Thyroid Neoplasms | 2 | D013964 | ClinicalTrials |
| Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
| Esophageal Neoplasms | 2 | D004938 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Endometrial Neoplasms | 2 | D016889 | ClinicalTrials |
| Leukemia | 1 | D007938 | ClinicalTrials |
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
| Lung Neoplasms | 1 | D008175 | ClinicalTrials |
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Primary Myelofibrosis | 1 | D055728 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Small Cell Lung Carcinoma | 1 | D055752 | ClinicalTrials |
| Gastrointestinal Stromal Tumors | 1 | D046152 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 944396-07-0 |
| ChEBI | 71954 |
| ChEMBL | CHEMBL2017974 |
| DrugBank | DB11666 |
| EPA CompTox | DTXSID50241486 |
| FDA SRS | 0ZM2Z182GD |
| Guide to Pharmacology | 7878 |
| PDB | SD5 |
| PubChem | 16654980 |
| SureChEMBL | SCHEMBL146956 |
| ZINC | ZINC000043154039 |